Outpatient Clinical Trial in Dogs With Leptospirosis Treated With Enrofloxacin Hydrochloride-Dihydrate (ENRO-C)
Pharmacokinetics of enrofloxacin HCl-2H2O (enro-C) in dogs and Monte-Carlo simulations against Leptospira spp. prompted a clinical study to treat the clinically apparent phase of this disease. Leptospirosis was diagnosed by real-time PCR from blood, micro-agglutination titers (MAT), clinical signs a...
Main Authors: | Lilia Gutierrez, Jesús Mendoza, Ana Bertha Rangel, Graciela Tapia, Maria Josefa Bernad, Hector Sumano |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-10-01
|
Series: | Frontiers in Veterinary Science |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fvets.2019.00360/full |
Similar Items
-
Treatment of Bovine Leptospirosis with Enrofloxacin HCl 2H<sub>2</sub>O (Enro-C): A Clinical Trial
by: Jesús Mendoza Bautista, et al.
Published: (2022-09-01) -
Oral Plus Topical Administration of Enrofloxacin-Hydrochloride-Dihydrate for the Treatment of Unresponsive Canine Pyoderma. A Clinical Trial
by: Lilia Gutierrez, et al.
Published: (2020-05-01) -
Bioequivalence Comparison of Seventeen Commercial Oral Enrofloxacins against the Original Pioneer Preparation in Broilers
by: Hector Sumano, et al.
Published: (2006-02-01) -
Evaluation of a Tasteless Enrofloxacin Pharmaceutical Preparation for Cats. Naive Pooled-Sample Approach to Study Its Pharmacokinetics
by: Lilia Gutierrez, et al.
Published: (2021-08-01) -
Clinical Efficacy of Enrofloxacin HCl-2H2O (ENRO-C) in a Sheep Leptospirosis Outbreak
by: Jesus MENDOZA, et al.
Published: (2022-05-01)